TSH Biopharm Corporation Limited (TPEX:8432)
Taiwan · Delayed Price · Currency is TWD 48.80
0.00 (0.00%)
Jul 30, 2026, 1:30 PM CST
TSH Biopharm Corporation Financials Overview
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 1,335 | 1,337 | 1,116 | 810.92 | 741.07 | 413.48 |
Revenue Growth | 11.05% | 19.79% | 37.59% | 9.43% | 79.22% | -7.68% |
Gross Profit Gross Profit Growth | 686.94 | 680.74 | 582.76 | 399.9 | 389.87 | 247.36 |
Operating Income Operating Income Growth | 228.46 | 218.37 | 169.86 | 63.63 | 66.03 | 55.62 |
Net Income Net Income Growth | 147.56 | 139.26 | 113.09 | 61.99 | 61.89 | 47.11 |
Earnings Per Share EPS Growth | 3.84 | 3.62 | 2.94 | 1.61 | 1.61 | 1.23 |
EPS Growth | 43.81% | 23.13% | 82.61% | 0% | 31.23% | -23.32% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cardiovascular and Gastrointestinal Drugs Business Group Cardiovascular and Gastrointestinal Drugs Business Group Growth | 687.41 | 656.95 | 628.51 | 497.31 | 647.38 | 413.48 |
Reinvestment Business Group Reinvestment Business Group Growth | 734.08 | 765.97 | 551.28 | 313.61 | 93.69 | - |
Adjustment and Elimination Adjustment and Elimination Growth | -86.27 | -86.4 | -64.07 | - | - | - |
Total Total Growth | 1,335 | 1,337 | 1,116 | 810.92 | 741.07 | 413.48 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 1,069 | 932.28 | 897.36 | 772.12 | 815.77 | 733.41 |
Total Debt Total Debt Growth | 17.14 | 18.64 | 20.43 | 7.4 | 63.13 | 4.57 |
Net Cash (Debt) Net Cash Growth | 1,052 | 913.64 | 876.93 | 764.73 | 752.64 | 728.84 |
Net Cash Growth | 20.33% | 4.19% | 14.67% | 1.60% | 3.27% | 1.67% |
Net Cash Per Share Net Cash Per Share Growth | 27.35 | 23.75 | 22.81 | 19.90 | 19.57 | 18.96 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 279.53 | 139.52 | 183.77 | 33.87 | 34.35 | 68.71 |
Capital Expenditures CapEx Growth | -3.18 | -4.52 | -1.73 | -5.38 | -3.73 | -0.38 |
Free Cash Flow Free Cash Flow Growth | 276.34 | 135 | 182.04 | 28.49 | 30.62 | 68.33 |
Free Cash Flow Growth | 79.29% | -25.84% | 538.93% | -6.96% | -55.18% | 604.75% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 51.45% | 50.93% | 52.23% | 49.31% | 52.61% | 59.82% |
Operating Margin | 17.11% | 16.34% | 15.22% | 7.85% | 8.91% | 13.45% |
Pretax Margin | 18.34% | 17.57% | 15.54% | 9.38% | 10.96% | 14.89% |
Profit Margin | 11.05% | 10.42% | 10.14% | 7.64% | 8.35% | 11.39% |
FCF Margin | 20.70% | 10.10% | 16.32% | 3.51% | 4.13% | 16.52% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 2.610 | 2.610 | 2.120 | 1.280 | 1.600 | 1.500 |
Dividend Per Share Growth | 23.11% | 23.11% | 65.63% | -20.00% | 6.67% | -16.67% |
Dividend Yield | 5.22% | 4.69% | 3.80% | 2.85% | 3.91% | 4.05% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 12.71 | 16.13 | 20.81 | 31.16 | 29.50 | 36.27 |
Forward PE | - | 18.74 | 18.74 | 18.74 | 18.74 | 18.74 |
P/FCF Ratio | 6.78 | 16.64 | 12.93 | 67.79 | 59.62 | 25.01 |
PS Ratio | 1.40 | 1.68 | 2.11 | 2.38 | 2.46 | 4.13 |